Jan 05, 2026
1:3000
For every 3000 shares held, investors received 1. The price per share adjusted from $1.00 to $3000.00.
The split itself did not change the total investment value.
Can-Fite BioPharma Ltd. (TASE:CANF) operates in the Pharmaceuticals: major industry.
Can-Fite BioPharma Ltd. company overviewCan-Fite BioPharma Ltd.'s most recent stock split was on January 5, 2026. It was a 1-for-3000 reverse split, so shareholders received 1 share for every 3000 they held.
Can-Fite BioPharma Ltd. (TASE:CANF) has split its stock 2 times: a 1-for-25 reverse split on May 12, 2013 and a 1-for-3000 reverse split on January 5, 2026.
Can-Fite BioPharma Ltd. has split its stock 2 times. This history records 2 reverse splits between May 12, 2013 and January 5, 2026.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Can-Fite BioPharma Ltd.'s 1-for-3000 reverse split on January 5, 2026, every 3000 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Can-Fite BioPharma Ltd. has not announced a new split in our records. Its most recent split was on January 5, 2026, less than a year ago. Companies announce splits in advance, and any new TASE:CANF split will appear on this page.
Already premium?